A carregar...
Effect of Aclidinium Bromide on Exacerbations in Patients with Moderate-to-Severe COPD: A Pooled Analysis of Five Phase III, Randomized, Placebo-Controlled Studies
We investigated the effect of the long-acting muscarinic antagonist aclidinium bromide on chronic obstructive pulmonary disease (COPD) exacerbations by pooling data from five randomized, placebo-controlled, parallel-group Phase III studies of 3–6 months’ duration. Data were pooled from the aclidiniu...
Na minha lista:
Publicado no: | COPD |
---|---|
Main Authors: | , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Taylor & Francis
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5152596/ https://ncbi.nlm.nih.gov/pubmed/27159613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/15412555.2016.1170111 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|